Liz Vecchio

View Scopus Profile

EmailLiz.Vecchio@monash.edu

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 Active

Formyl peptide receptor biased agonists as novel cardioprotective agents against myocardial infarction.
Vecchio, L.
25/08/20 → 28/02/26
Project: Research

7 Article
3 Review Article

Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists
Deora, G. S., Qin, C. X., Vecchio, E. A., Debono, A. J., Priebbenow, D. L., Brady, R. M., Beveridge, J., Teguh, S. C., Deo, M., May, L. T., Krippner, G., Ritchie, R. H. & Baell, J. B., 23 May 2019, In: Journal of Medicinal Chemistry. 62, 10, p. 5242-5248 7 p.
Research output: Contribution to journal › Article › Research › peer-review

5 Citations (Scopus)
The adenosine A _2B G protein-coupled receptor: Recent advances and therapeutic implications
Vecchio, E. A., White, P. J. & May, L. T., 1 Jan 2019, In: Pharmacology and Therapeutics. 198, p. 20-33 14 p.
Research output: Contribution to journal › Review Article › Research › peer-review

15 Citations (Scopus)
New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism
Vecchio, E. A., Baltos, J. A., Nguyen, A. T. N., Christopoulos, A., White, P. J. & May, L. T., 1 Nov 2018, In: British Journal of Pharmacology. 175, 21, p. 4036-4046 11 p.
Research output: Contribution to journal › Review Article › Research › peer-review

20 Citations (Scopus)
Capadenoson, a clinically trialed partial adenosine A₁ receptor agonist, can stimulate adenosine A_2B receptor biased agonism
Baltos, J-A., Vecchio, E. A., Harris, M. A., Qin, C. X., Ritchie, R. H., Christopoulos, A., White, P. J. & May, L. T., 1 Jul 2017, In: Biochemical Pharmacology. 135, p. 79–89 11 p.
Research output: Contribution to journal › Article › Research › peer-review

24 Citations (Scopus)
Structure of the adenosine A₁ receptor reveals the basis for subtype selectivity
Glukhova, A., Thal, D. M., Nguyen, A. T., Vecchio, L., Jorg, M., Scammells, P. J., May, L. T., Sexton, P. M. & Christopoulos, A., 23 Feb 2017, In: Cell. 168, 5, p. 867-877.e13
Research output: Contribution to journal › Article › Research › peer-review

134 Citations (Scopus)

Liz Vecchio

Network

Dive into details

Formyl peptide receptor biased agonists as novel cardioprotective agents against myocardial infarction.

Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists

The adenosine A _2B G protein-coupled receptor: Recent advances and therapeutic implications

New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism

Capadenoson, a clinically trialed partial adenosine A₁ receptor agonist, can stimulate adenosine A_2B receptor biased agonism

Structure of the adenosine A₁ receptor reveals the basis for subtype selectivity

Liz Vecchio

Network

Projects

Formyl peptide receptor biased agonists as novel cardioprotective agents against myocardial infarction.

Research output

Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists

The adenosine A 2B G protein-coupled receptor: Recent advances and therapeutic implications

New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism

Capadenoson, a clinically trialed partial adenosine A1 receptor agonist, can stimulate adenosine A2B receptor biased agonism

Structure of the adenosine A1 receptor reveals the basis for subtype selectivity

The adenosine A _2B G protein-coupled receptor: Recent advances and therapeutic implications

Capadenoson, a clinically trialed partial adenosine A₁ receptor agonist, can stimulate adenosine A_2B receptor biased agonism

Structure of the adenosine A₁ receptor reveals the basis for subtype selectivity